Sasta ParchaWahi dawai. Sahi daam.

Salt / ingredient

Carbamazepine Prolonged-Release 200mg

Prevents seizures; nerve pain

MRP data last verified: August 2026. Source: NPPA Pharma Sahi Daam, reproduced under the NPPA copyright policy.

More about this medicine

Reference information

About Carbamazepine Prolonged-Release

Source: OpenFDA

This information is from US FDA labels, for reference only. Always follow your doctor's advice.

Common side effects
  • headache
  • nausea
  • diarrhea
  • vomiting
  • dizziness
  • fatigue
  • abdominal pain
  • constipation
  • rash
  • drowsiness
Safety advice
  • Consult your doctor before use if pregnant or breastfeeding.
  • May affect the liver. Tell your doctor if you have liver problems.
  • May affect the kidneys. Tell your doctor if you have kidney problems.
  • Avoid or limit alcohol while taking this medicine.
  • May cause drowsiness. Be careful driving or operating machines.
  • Stop use and seek emergency help if you have signs of a severe allergic reaction.
Uses
  • Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug.
  • Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: 1.
  • Partial seizures with complex symptomatology (psychomotor, temporal lobe).
  • Patients with these seizures appear to show greater improvement than those with other types.
  • Generalized tonic-clonic seizures (grand mal).
How to take
  • () Carbamazepine suspension in combination with liquid chlorpromazine or thioridazine results in precipitate formation, and, in the case of chlorpromazine, there has been a report of patient passing an orange rubbery precipitate in the stool following coadministration of the two drugs (see , Drug Interactions).
  • Because the extent to which this occurs with other liquid medications is not known, Carbamazepine suspension should not be administered simultaneously with other liquid medications or diluents.
  • Monitoring of blood levels has increased the efficacy and safety of anticonvulsants (see , Laboratory Tests).
  • Dosage should be adjusted to the needs of the individual patient.
  • A low initial daily dosage with a gradual increase is advised.

Frequently Asked Questions about Carbamazepine Prolonged-Release 200mg

What is the price of Carbamazepine Prolonged-Release 200mg in India?

The price of Carbamazepine Prolonged-Release 200mg in India depends on the manufacturer and channel. Official Government Jan Aushadhi generic rates start at ₹1.41 per unit.Private commercial brands vary from low-cost options to higher-priced branded formulations.

Is a Government Jan Aushadhi generic available for Carbamazepine Prolonged-Release 200mg?

Carbamazepine Prolonged-Release 200mg is listed under PMBI Jan Aushadhi (PMBI Code 1152) at ₹14.07 per pack.

How to find lower-cost substitutes for Carbamazepine Prolonged-Release 200mg?

Search the active salt formulation (Carbamazepine Prolonged-Release 200mg) on Sasta Parcha to view private-brand substitutes ranked strictly low-to-high by per-unit price. Always consult your prescribing doctor or pharmacist before changing medicine brands.